The Immune Tolerance Network (ITN) is a collaborative network for clinical research, funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Our mission is to accelerate the clinical development of immune tolerance therapies in asthma and aller...See more
Headquarter United States of America |
Countries of operation Australia, United States of America |
Funding status Private |
Company type SME |